Generic substitution for cyclosporine: what should we be looking for in new formulations? (Q77175787)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Generic substitution for cyclosporine: what should we be looking for in new formulations? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

D W Holt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

Transplantation Proceedings

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1652-1653

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

Generic medicines--can quality be assured?

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Risk factors for chronic rejection in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Causes of kidney allograft loss in a large pediatric population at a single center

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. I: Blood cyclosporine concentrations and other risk factors for cardiac allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Clinical development of a cyclosporine microemulsion in transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Blood cyclosporin concentrations and renal allograft dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Low intrapatient variability of blood cyclosporine levels is correlated with excellent graft survival

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Bioequivalence requirements for generic products

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Simple bioequivalence criteria: are they relevant to critical dose drugs? Experience gained from cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Which cyclosporin formulation?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

Switching between cyclosporin formulations. What are the risks?

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900377-7

7 January 2021

10.1016/S0041-1345(98)00377-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9723228%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference